Combination of amlodipine besylate and olmesartan medoxomil provides greater reduction in blood pressure compared with monotherapy in subjects with and without diabetes

被引：0

作者：

Bakris, G. ^{[1
]}

Karki, S. ^{[2
]}

Lee, J. ^{[2
]}

Heyrman, R. ^{[2
]}

机构：

[1] Univ Chicago, Sch Med, Chicago, IL 60637 USA

[2] Daiichi Sankyo Inc, Parsippany, NJ USA

来源：

JOURNAL OF HYPERTENSION | 2008年 / 26卷

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：S190 / S190

页数：1

共 50 条

[41] Reduction in blood pressure in patients treated with vildagliptin as monotherapy or in combination with metformin for type 2 diabetes
Nathwani, Ameet
Lebeaut, Alexandre
Byiers, Stuart
Gimpelewicz, Claudio
Chang, Ih
DIABETES, 2006, 55 : A113 - A113
[42] COMBINATION THERAPY WITH ALISKIREN/HCTZ OR ALISKIREN/AMLODIPINE REDUCES CENTRAL SYSTOLIC BLOOD PRESSURE TO A GREATER DEGREE THAN AMLODIPINE MONOTHERAPY IN AFRICAN AMERICANS WITH STAGE 2 HYPERTENSION
Ferdinand, K.
Townsend, R.
Pool, J.
Black, H.
Weinberger, M.
Weitzman, R.
Israel, M.
Purkayastha, D.
Izzo, J.
ETHNICITY & DISEASE, 2010, 20 (04) : S38 - S38
[43] The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension (vol 30 pg 1086, 2013)
Ruilope, Luis
Schaefer, Angie
ADVANCES IN THERAPY, 2014, 31 (04) : 472 - 472
[44] The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension (vol 30, pg 1086, 2013)
Ruilope, Luis
Schaefer, Angie
ADVANCES IN THERAPY, 2014, 31 (02) : 243 - 243
[45] The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension (vol 30, pg 1086, 2013)
Ruilope, Luis
Schaefer, Angie
ADVANCES IN THERAPY, 2015, 32 (02) : 184 - 185
[46] DIFFERENTIAL EFFECTS OF ALISKIREN/AMLODIPINE COMBINATION AND HIGH-DOSE AMLODIPINE MONOTHERAPY ON AMBULATORY BLOOD PRESSURE AND TARGET ORGAN PROTECTION IN HYPERTENSIVES AND ITS INADEQUATE BLOOD PRESSURE RESPONSE IN THOSE WHO WITH DIABETES
Mizuno, Hiroyuki
Hoshide, Satoshi
Fukutomi, Motoki
Kario, Kazuomi
JOURNAL OF HYPERTENSION, 2018, 36 : E155 - E155
[47] Fixed-combination olmesartan/amlodipine (OLM/AML) was superior to perindopril plus amlodipine (PER/AML) in reducing central systolic blood pressure (CSBP) in hypertensive patients with diabetes
Ruilope, L. M.
EUROPEAN HEART JOURNAL, 2014, 35 : 572 - 572
[48] SWITCH TO A FIXED-DOSE COMBINATION THERAPY WITH TELMISARTAN AND AMLODIPINE PROVIDES SIGNIFICANT BLOOD PRESSURE REDUCTION AND CONTROL IN PATIENTS NOT ADEQUATELY CONTROLLED WITH AMLODIPINE 10 MG
Neldam, S.
Edwards, C.
JOURNAL OF HYPERTENSION, 2009, 27 : S277 - S277
[49] Daytime Systolic Ambulatory Blood Pressure With a Two-Step Switch From Candesartan to Olmesartan Monotherapy and the Fixed-Dose Combination of Olmesartan/Amlodipine in Patients With Uncontrolled Essential Hypertension (SEVICONTROL-2)
Bramlage, Peter
Zemmrich, Claudia
Gansz, Andrea
Sturm, Claus-Dieter
Fimmers, Rolf
Nadal, Jennifer
Schmieder, Roland E.
Schrader, Joachim
Lueders, Stephan
JOURNAL OF CLINICAL HYPERTENSION, 2014, 16 (01): : 41 - 46
[50] TRIPLE COMBINATION OF VALSARTAN, AMLODIPINE, AND HCTZ PROVIDES EFFECTIVE REDUCTION OF BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION NOT CONTROLLED BY DUAL THERAPY WITH AMLODIPINE PLUS VALSARTAN OR VALSARTAN PLUS HCTZ
Braun, N.
Handrock, R.
Klebs, S.
Schweizer, J.
JOURNAL OF HYPERTENSION, 2009, 27 : S272 - S273

← 1 2 3 4 5 →